| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Prime Medicine, Inc. | 10%+ Owner | Common Stock | 10,100,058 | $63,125,363 | $6.25 | 21 Jun 2023 | By GV 2019, L.P. |
| IonQ, Inc. | Former 10% Group Member | Common Stock | 4,556,532 | $60,206,369 | $13.21 | 11 Apr 2022 | By GV 2019 L.P. |
| Verve Therapeutics, Inc. | 10%+ Owner | Common Stock | 4,472,509 | $44,725,090 | $10.00 | 21 Jun 2021 | By GV 2019 L.P. |
| Prime Medicine, Inc. | 10%+ Owner | Common Stock | 1,762,440 | $11,015,250 | $6.25 | 20 Jun 2023 | By GV 2021, L.P. |
| Prime Medicine, Inc. | 10%+ Owner | Common Stock | 0 | $0 | $14.97 | 21 Jun 2023 | By Alphabet Holdings LLC |
| Prime Medicine, Inc. | 10%+ Owner | Series A Convertible Preferred Stock | 0 | 24 Oct 2022 | By GV 2019, L.P. | ||
| Prime Medicine, Inc. | 10%+ Owner | Series B Convertible Preferred Stock | 0 | 24 Oct 2022 | By GV 2021, L.P. | ||
| Verve Therapeutics, Inc. | 10%+ Owner | Series A-2 Preferred Stock | 0 | 21 Jun 2021 | By GV 2019 L.P. | ||
| Verve Therapeutics, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | 21 Jun 2021 | By GV 2019 L.P. |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PRME | Prime Medicine, Inc. | 20 Jun 2023 | 4 | -$847,744 | 4 | 10%+ Owner | 22 Jun 2023, 17:03 |
| PRME | Prime Medicine, Inc. | 15 Jun 2023 | 4 | -$1,092,435 | 4 | 10%+ Owner | 20 Jun 2023, 16:17 |
| PRME | Prime Medicine, Inc. | 13 Jun 2023 | 4 | -$855,787 | 4 | 10%+ Owner | 15 Jun 2023, 16:22 |
| PRME | Prime Medicine, Inc. | 09 Jun 2023 | 4 | -$467,135 | 4 | 10%+ Owner | 13 Jun 2023, 16:20 |
| PRME | Prime Medicine, Inc. | 07 Jun 2023 | 4 | -$332,557 | 4 | 10%+ Owner | 09 Jun 2023, 16:24 |
| PRME | Prime Medicine, Inc. | 05 Jun 2023 | 4 | -$884,777 | 4 | 10%+ Owner | 07 Jun 2023, 16:17 |
| PRME | Prime Medicine, Inc. | 31 May 2023 | 5 | -$876,198 | 4 | 10%+ Owner | 02 Jun 2023, 16:17 |
| PRME | Prime Medicine, Inc. | 26 May 2023 | 4 | -$402,844 | 4 | 10%+ Owner | 31 May 2023, 16:15 |
| PRME | Prime Medicine, Inc. | 24 May 2023 | 4 | -$417,893 | 4 | 10%+ Owner | 26 May 2023, 16:17 |
| PRME | Prime Medicine, Inc. | 22 May 2023 | 4 | -$1,889,739 | 4 | 10%+ Owner | 24 May 2023, 17:07 |
| PRME | Prime Medicine, Inc. | 18 May 2023 | 5 | -$1,230,338 | 4 | 10%+ Owner | 22 May 2023, 16:21 |
| PRME | Prime Medicine, Inc. | 16 May 2023 | 2 | -$829,275 | 4 | 10%+ Owner | 18 May 2023, 16:16 |
| PRME | Prime Medicine, Inc. | 12 May 2023 | 2 | -$2,359,309 | 4 | 10%+ Owner | 16 May 2023, 16:16 |
| PRME | Prime Medicine, Inc. | 10 May 2023 | 3 | -$1,575,337 | 4 | 10%+ Owner | 12 May 2023, 16:16 |
| PRME | Prime Medicine, Inc. | 08 May 2023 | 2 | -$5,946,340 | 4 | 10%+ Owner | 10 May 2023, 16:17 |
| PRME | Prime Medicine, Inc. | 24 Oct 2022 | 5 | +$13,600,000 | 4 | 10%+ Owner | 26 Oct 2022, 20:02 |
| PRME | Prime Medicine, Inc. | 19 Oct 2022 | 0 | $0 | 3 | 10%+ Owner | 19 Oct 2022, 20:08 |
| IONQ | IonQ, Inc. | 11 Apr 2022 | 0 | $0 | 4 | Former 10% Group Member | 12 Apr 2022, 18:17 |
| IONQ | IonQ, Inc. | 30 Sep 2021 | 0 | $0 | 3/A | 10%+ Owner | 08 Apr 2022, 17:39 |
| VERV | Verve Therapeutics, Inc. | 21 Jun 2021 | 4 | $0 | 4 | 10%+ Owner | 22 Jun 2021, 17:18 |
| VERV | Verve Therapeutics, Inc. | 16 Jun 2021 | 0 | $0 | 3 | 10%+ Owner | 16 Jun 2021, 19:28 |